GeNeuro is a biotechnology company developing innovative treatments against inflammatory and neurodegenerative disorders associated with Human Endogenous Retroviruses (HERVs).
We are committed to fight the progression of disability in Multiple Sclerosis #FightMS and other neurodegenerative diseases #ALS #LongCOVID
Our Community Guidelines: http://bit.ly/36y9YCE
Location: Switzerland, Geneva
Employees: 11-50
Total raised: $69.11M
Founded date: 2006
Investors 1
| Date | Name | Website |
| - | VentureLab | venturelab... |
Funding Rounds 4
| Date | Series | Amount | Investors |
| 06.02.2024 | - | $5.38M | - |
| 15.07.2021 | - | $7.09M | - |
| 31.01.2020 | - | $19.42M | - |
| 15.04.2016 | - | $37.24M | - |
Mentions in press and media 21
| Date | Title | Description | Source |
| 06.02.2024 | Swiss biotech company GeNeuro secures €5M to accelerate post... | Read this article in: Geneva-based GeNeuro, a biopharmaceutical company, announced on Friday, Februa... | siliconcan... |
| 14.12.2021 | GeNeuro receives CHF 6.7 million in funding from the Swiss g... | Geneva - GeNeuro (Euronext Paris: CH0308403085 - GNRO), a biopharmaceutical company developing novel... | marketscre... |
| 13.12.2021 | Geneuro Receives CHF 6.7 Million (EUR 6.4 Million) in Fundin... | Regulatory News: GeNeuro (Euronext Paris: CH0308403085 - GNRO) (Paris:GNRO), a biopharmaceutical com... | marketscre... |
| 13.12.2021 | Federal government signs four contracts for the development ... | startuptic... | |
| 13.12.2021 | Geneuro Receives EUR 6.4 Million in Funding from the Swiss G... | GeNeuro announced that its development in Long-COVID is one of the four projects selected by the Swi... | marketscre... |
| 15.07.2021 | GeNeuro raises 6 million euros in a private placement | With offices in Geneva and R&D facilities in Lyon, France, GeNeuro is on the mission is to devel... | startuptic... |
| 13.07.2021 | GeNeuro: successful 6 million private placement | NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INT... | marketscre... |
| 31.01.2020 | GeNeuro closes €17.5 million private placement | startuptic... | |
| 31.01.2020 | GeNeuro closes €17.5 million private placement | GeNeuro‘s mission is to develop safe and effective treatments against neurological disorders and aut... | startuptic... |
| 26.03.2018 | GeNeuro: 12-month-results underpinning hope | startuptic... |
Show more